R. Ramesh

发表

Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.

Mark S. Sundrud, A. Regev, R. Young, 2014, Immunity.

In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists

Mark S. Sundrud, Scott P. Davis, Jonathan A. Hill, 2015, Immunology.

and Suppresses Cutaneous Inflammation In Regulates Th17 Signature Gene Expression t γ Pharmacologic Inhibition of ROR

Mark S. Sundrud, Jianfei Yang, E. Baloglu, 2014 .

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids

Mark S. Sundrud, R. Ramesh, J. McCauley, 2014, The Journal of experimental medicine.

Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo

Mark S. Sundrud, Jianfei Yang, E. Baloglu, 2014, The Journal of Immunology.

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies

Niladri Roy Chowdhury, T. Hu, R. Ramesh, 2022, Journal for ImmunoTherapy of Cancer.

Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization.

R. Ramesh, B. Slusher, M. Hedley, 2010, Cellular immunology.

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.

John A. Tallarico, Charles A. Wartchow, G. Dranoff, 2023, Cell chemical biology.

Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor

T. Hu, G. Dranoff, R. Ramesh, 2022, Immunotherapy advances.

Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells

Mark S. Sundrud, R. Ramesh, D. Unutmaz, 2011, The Journal of experimental medicine.